Documents & Downloads

Socrodeucitinib

TYK2 Inhibitor

Socrodeucitinib is a selective inhibitor of tyrosine kinase 2 (TYK2) with an IC50 value of 1.41 nM. This orally bioavailable compound demonstrates anti-inflammatory activity by disrupting TYK2-mediated cytokine signaling pathways, leading to a reduction in inflammatory factor secretion. Socrodeucitinib holds promise for research applications focused on autoimmune diseases, including psoriasis, and other inflammatory conditions.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2457365-35-2
Applications	TYK2 Inhibitor
Formula	C₂₂H₂₁D₃N₈O₃
Molecular Weight	451.50
SMILES	COC1=C(C2=NN(C3CC3)C=N2)C=CC=C1NC4=C(N=NC(NC(C5CC5)=O)=C4)C(NC([2H])([2H])[2H])=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.